...
首页> 外文期刊>Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases >Identification of broadly reactive epitopes targeting major glycoproteins of Herpes simplex virus (HSV) 1 and 2-An immunoinformatics analysis
【24h】

Identification of broadly reactive epitopes targeting major glycoproteins of Herpes simplex virus (HSV) 1 and 2-An immunoinformatics analysis

机译:鉴定疱疹病毒(HSV)1和2-免疫信息分析的主要糖蛋白靶向靶向糖蛋白的广泛反应性表位

获取原文
获取原文并翻译 | 示例
           

摘要

Infections due to both HSV-1 and HSV-2 constitute an enormous health burden worldwide. Development of vaccine against herpes infections is a WHO supported public health priority. The viral glycoproteins have always been the major hotspots for vaccine designing. The present study was aimed to identify the conserved T and B cell epitopes in the major glycoproteins of both HSV-1 and HSV-2 via rigorous computational approaches. Identification of promiscuous T cell epitopes is of utmost importance in vaccine designing as such epitopes are capable of binding to several allelic forms of HLA and could generate effective immune response in the host. The criteria designed for identification of T and B cell epitopes was that it should be conserved in both HSV-1 and 2, promiscuous, have high affinity towards HLA alleles, should be located on the surface of glycoproteins and not be present in the glycosylation sites. This study led to the identification of 17 HLA Class II and 26 HLA Class I T cell epitopes, 9 linear and some conformational B cell epitopes. The identified T cell epitopes were further subjected to molecular docking analysis to analyze their binding patterns. Altogether we have identified 4 most promising regions in glycoproteins (2-gB, 1-gD, 1-gH) of HSV-1 and 2 which are promiscuous to HLA Class II alleles and have overlapping HLA Class I and B cell epitopes, which could be very useful in generating both arms of immune response in the host i.e. adaptive as well as humoral immunity. Further the authors propose the cross-validation of the identified epitopes in experimental settings for confirming their immunogenicity to support the present findings.
机译:HSV-1和HSV-2引起的感染构成全球巨大的健康负担。对疱疹感染的疫苗的发展是一个支持公共卫生优先权的人。病毒糖蛋白始终是疫苗设计的主要热点。本研究旨在通过严格的计算方法鉴定HSV-1和HSV-2的主要糖蛋白中的保守T和B细胞表位。鉴定混杂性T细胞表位在疫苗设计中至关重要,因为这种表位能够结合若干等位基因形式的HLA并且可以在宿主中产生有效的免疫应答。设计用于鉴定的T和B细胞表位的标准是它应该在HSV-1和2中保存,混杂的是对HLA等位基因具有高亲和力,应位于糖蛋白的表面上,不存在于糖基化位点上。该研究导致鉴定17 HLA II类和26类HLA I类T细胞表位,9个线性和一些构象B细胞表位。鉴定的T细胞表位进一步进行分子对接分析以分析它们的结合模式。完全我们已经鉴定了HSV-1和2的糖蛋白(2-GB,1-Gd,1-GH)中的4个最有前景的区域,其对HLA II类等位基因混杂化,并且具有重叠的HLA I类和B细胞表位,可以在宿主中产生免疫应答的双臂,即适应性以及体液免疫,非常有用。此外,作者提出了鉴定的表位在实验环境中的交叉验证,以确认其免疫原性以支持本发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号